Critical State of "Remission-Recurrence" of Ulcerative Colitis
Observational · No treatment assigned · 1 site · Beijing Hospital of Traditional Chinese Medicine
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Ulcerative Colitis. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Age range not stated in the record
- Any sex
Some of the main requirements, copied from the record:
- Patients who meet the criteria based on the clinical characteristics of ulcerative colitis patients in the "remission recurrence" critical state, combined with clinical symptoms, are diagnosed with ulcerative colitis through imaging,…
- Patients with comprehensive laboratory testing indicators.
There are also 8 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 100 participants are expected to take part.
- Start date: 2024-09-19.
- Main results expected around 2025-05 (estimate from the record).
- 1 study site listed (1 marked recruiting) in China.
Main thing being measured
- The recurrence rate of patients (The recurrence status of patients will be recorded during the 6-month follow-up period, and the recurrence rate will be…)
In the researchers’ words
This study will recruit 100 patients with ulcerative colitis in remission for a 6-month non intervention follow-up observation. During the study, their conditions will be recorded truthfully, including general information, disease-related symptoms and signs, inflammatory bowel disease questionnaire, anxiety self-assessment scale, depression self-assessment scale, etc., every month.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Ulcerative Colitis |
| Lead sponsor | Beijing Hospital of Traditional Chinese Medicine |
| Enrollment | 100 (estimated) |
| Start date | 2024-09-19 |
| Primary completion (est.) | 2025-05 |
| First posted | 2024-11-19 |
| Last updated | 2024-11-19 |
| Official title | Research on the Biological Basis of "Disease-Syndrome-Formula" in the Critical State of "Remission-Recurrence" of Ulcerative Colitis (Joint Application A) |
| ClinicalTrials.gov ID | NCT06694883 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Patients who meet the criteria based on the clinical characteristics of ulcerative colitis patients in the "remission recurrence" critical state, combined with clinical symptoms, are diagnosed with ulcerative colitis through imaging, endoscopy, laboratory, and histopathological examinations; * Patients with comprehensive laboratory testing indicators. Exclusion Criteria: * Patients with incomplete case information records; * Patients who have not completed serological tests; * Complications including intestinal obstruction, intestinal perforation, toxic megacolon, and severe local stenosis; * Diagnosed or suspected patients with coexisting uncertain colitis, infectious or ischemic colitis; * Patients with coexisting local or systemic infections, any malignant diseases, or autoimmune diseases; * Merge primary diseases such as respiratory, circulatory, neurological, endocrine, and hematological disorders; * Individuals at risk of developing cancer; * regnant or lactating women.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Hospital of Traditional Chinese Medicine, Capital Medical University | Dongcheng, Beijing Municipality | China | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.